A Tiny Brain Molecule May Trigger a Chain Reaction Linked to Autism
Summary
Recent research reveals a hidden molecular chain reaction in the brain that may accelerate cellular systems in autism. Scientists have discovered a method to deactivate this reaction, potentially paving the way for new therapeutic approaches in autism treatment.
Key Insights
What is the 'tiny brain molecule' and how does it relate to autism?
The tiny brain molecule is nitric oxide, a chemical messenger that triggers a chain reaction by modifying TSC2 through S-nitrosylation, leading to overactivation of the mTOR pathway, which regulates cell growth and is dysregulated in autism.
Sources:
[1]
How was this chain reaction studied and what therapeutic potential does it have?
Researchers validated the pathway in clinical samples from children with SHANK3 mutations and idiopathic autism, showing reduced TSC2 and hyperactive mTOR; using nitric oxide inhibitors prevented TSC2 modification, normalized mTOR activity, and improved autism-related cellular functions, suggesting new drug targets.
Sources:
[1]